Wegovy price in the Philippines drops up to 17 percent for the starting pens

The Wegovy price in the Philippines has come down for the first three steps of treatment. Novo Nordisk Philippines cut the suggested retail price of the two lowest strengths to P8,188 per pen from P9,900, about 17 percent lower, and the third strength to P9,279. Each pen holds four weekly doses, so one pen covers about a month. Here is what the change means for cost, who pays less, and what it leaves out.

The new list for the starting pens

The new prices were announced by Novo Nordisk Philippines and reported by the Philippine Star and BusinessMirror on October 22. They are suggested retail prices, so the amount a pharmacy actually charges can still vary from one store to the next. The cut applies only to the three lowest strengths of the once weekly injection. The first two strengths share one price, now P8,188 per pen instead of P9,900. The third strength moves from P9,900 to P9,279, a fall of about 6 percent. Each pen contains four doses of its labelled strength, which is enough for four weeks when it is used once a week as prescribed. BusinessMirror dated the new prices to October 2026.

For a patient, the change in the Wegovy price in the Philippines is largest in the first two months. Under the old list, the starting pen and the second pen each cost P9,900, so the first eight weeks came to P19,800 before any reduction. Under the new list, the same two pens cost P16,376, a saving of P3,424 over two months. The third month is cheaper by P621. Because the first two strengths now share one price, stepping up from the starting strength to the second does not raise the monthly bill. The reports did not list prices for the higher strengths used later in treatment, and BusinessMirror noted that later steps may cost more, so a full year of therapy still costs well above these figures.

Who pays less and by how much

Senior citizens and persons with disabilities who qualify get a further 20 percent reduction on top of the new list price, according to the company. That brings the two lowest strengths to P6,550 per pen and the third strength to P7,423 per pen. For an older patient on a fixed pension, the starting month now lists at P6,550 before any pharmacy markup. Neither report mentioned PhilHealth or any other public insurer paying for the drug, so for most people the Wegovy price in the Philippines is still met out of pocket. Employer plans and private health maintenance organisations may treat it differently, and patients should ask their plan directly what it covers and on which conditions.

Under the new list, the same two pens cost P16,376, a saving of P3,424 over two months.

The company framed the cut as one part of a wider access problem. "Medicine costs are one part of the access challenge," said Wei Sun, general manager of Novo Nordisk Philippines. He added that steady availability, sound prescribing and medical follow up also count, and he called the price adjustment a single step toward meeting that need. Read plainly, a lower list price helps only people who already have a prescription, a doctor to follow them, and a licensed pharmacy that stocks the pen. Those three conditions are not spread evenly across the islands, and a new price list does not change them. Clinic fees, laboratory tests and travel also add to what a patient really spends each month.

Obesity in the Philippines and the case for a lower price

The cut lands as obesity rates rise. A National Nutrition Council report on the 2025 Updating Survey by the Food and Nutrition Research Institute of the Department of Science and Technology found that 44.5 percent of Filipino adults have overweight or obesity, up from 39.8 percent in 2023, BusinessMirror reported. That is close to one adult in two. A larger pool of people who might be offered treatment gives a drug maker a reason to lower the entry price and widen use. It does not mean that everyone with a high body mass index qualifies. Wegovy is a prescription medicine for weight management in eligible patients, used with a reduced calorie diet and more physical activity, and a doctor decides who fits.

The lower entry price also matters for the gray market. When the legal price of a pen is high, some buyers look for cheaper pens or compounded copies online, where nobody can vouch for what is inside, how it was stored, or whether it is the real product. A cut of this size narrows that gap only a little, because a month of treatment still costs more than P8,000 at the starting strengths. The safer route is to obtain the medicine with a valid prescription from a licensed pharmacy, which is also what the company advised. Readers who want the wider picture can follow our gray market reporting, which tracks unofficial channels without naming any seller or source.

What a month of Wegovy costs now

The table sets out the published figures per pen, where one pen covers four weekly doses. Added up, the Wegovy price in the Philippines for the first three months of treatment is now P25,655, against P29,700 under the old prices, a saving of P4,045 across the first quarter. With the reduction for senior citizens and persons with disabilities, the same three months list at P20,523. These are suggested prices, not guaranteed ones, and a pharmacy can charge more or less. The figures also leave out anything beyond the third strength, which is where many patients spend most of their time on treatment. For more on what treatment costs across markets, see our price desk.

Before filling a prescription, patients can confirm three things with the pharmacy: that the prescribed strength is in stock, what the shelf price actually is, and whether the senior or disability reduction has been applied. The total cost of care also includes consultations, laboratory tests and the later strengths, none of which this announcement changes. Prescribers may find that the flat price across the first two steps makes it easier to discuss the starting phase with a patient, while the cost of long term treatment remains an open question. Pharmacies will need to update shelf prices and make sure the reduction is applied correctly, since patients are likely to arrive with the new figures from the news.

Conclusion

The Wegovy price in the Philippines now starts at P8,188 per pen for the two lowest strengths, about 17 percent below the old P9,900, with P9,279 for the third strength and a further 20 percent reduction for eligible seniors and persons with disabilities. Prices for later strengths were not published. Check the shelf price with your pharmacy and ask your doctor what the full course would cost.